← Eichor
Condition: Short Stature Synced from ClinicalTrials.gov · July 28, 2026

Recruiting studies: Short Stature

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

Neuropsychological Assessment of Children and Adolescents With Turner Syndrome
Phase N/A · 3 location(s) · University Hospital, Angers · NCT03812913Comparison of Weekly Somatrogon to Daily Genotropin in Children Born Small for Gestational Age or With Idiopathic Short
Phase 3 · 32 location(s) · Rabin Medical Center · NCT07226089Trial Investigating the Efficacy and Safety of Weekly Lonapegsomatropin Compared to Daily Somatropin in Children and Ado
Phase 3 · 34 location(s) · Ascendis Pharma A/S · NCT07221851A Phase 2 Study of Vosoritide in Children With Idiopathic Short Stature
Phase 2 · 47 location(s) · BioMarin Pharmaceutical · NCT06382155Growth Hormone Replacement Therapy in Veterans With Mild Traumatic Brain Injury (mTBI) and Adult Growth Hormone Deficien
Phase 3 · 16 location(s) · VA Office of Research and Development · NCT04867317Role of Next Generation Sequencing in the Etiological Diagnosis of Permanent Congenital Hypothyroidism With in Situ Thyr
Phase N/A · 1 location(s) · IRCCS Azienda Ospedaliero-Universitaria di Bologna · NCT06728735Primordial Dwarfism Registry
Phase N/A · 1 location(s) · Nemours Children's Clinic · NCT04569149Long-term Efficacy and Safety Evaluation of Growth Hormone in Children in China(CGLS)
Phase N/A · 1 location(s) · Xiaoping Luo · NCT06110910Natural History Study for DNA Repair Disorders
Phase N/A · 1 location(s) · University of Minnesota · NCT05484570A Phase II Study of PEG-rhGH Injection for Short Children Born Small for Gestational Age: Efficacy, Safety, and Pharmaco
Phase 2 · 1 location(s) · Changchun GeneScience Pharmaceutical Co., Ltd. · NCT07260500Safety, Pharmacokinetic (PK) Profile and Efficacy of Inpegsomatropin Injection in Adults With Growth Hormone Deficiency
Phase 2 · 6 location(s) · Xiamen Amoytop Biotech Co., Ltd. · NCT07551804A Clinical Trial to Evaluate Efficacy and Safety of Navepegritide in Adolescents (12 - 18 Years of Age) With Achondropla
Phase 2 · 5 location(s) · Ascendis Pharma A/S · NCT06732895The Efficacy and Safety of Inpegsomatropin Injection in Children With Idiopathic Short Stature
Phase 3 · 38 location(s) · Xiamen Amoytop Biotech Co., Ltd. · NCT06927310Prospective Clinical Assessment Study in Children With Hypochondroplasia
Phase N/A · 25 location(s) · QED Therapeutics, a BridgeBio company · NCT06410976A Study to Assess Growth in Children With Idiopathic Short Stature
Phase N/A · 38 location(s) · BioMarin Pharmaceutical · NCT06309979REMS25: Study on the Use of REMS Technology in Diseases Commonly Associated With Reduced Bone Mineral Density (BMD)
NA · 1 location(s) · Meyer Children's Hospital IRCCS · NCT07412782A Post-Authorisation Safety Study (PASS) of Patients Treated With Lonapegsomatropin
Phase N/A · 27 location(s) · Ascendis Pharma Endocrinology Division A/S · NCT05775523Vosoritide for Short Stature in Turner Syndrome
Phase 2 · 1 location(s) · Roopa Kanakatti Shankar, MBBS, MS · NCT05849389Phase 3 Study of LUM-201 in Children With Growth Hormone Deficiency
Phase 3 · 43 location(s) · Lumos Pharma · NCT06948214Registry for Patients With Achondroplasia / Hypochondroplasia (OMPR-Ach/Hy)
Phase N/A · 1 location(s) · Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico · NCT05328050A Study of Vosoritide in Children With Noonan Syndrome With Inadequate Growth During or After Human Growth Hormone Treat
Phase 2 · 36 location(s) · BioMarin Pharmaceutical · NCT06668805The Efficacy and Safety of Inpegsomatropin Injection in Children With Short Stature Born Small for Gestational Age
Phase 3 · 49 location(s) · Xiamen Amoytop Biotech Co., Ltd. · NCT07309562Growth Hormone Replacement in Veterans With GWI and AGHD (GWIT)
Phase 2 · 2 location(s) · Baylor College of Medicine · NCT05355272Rare Disease Patient Registry & Natural History Study - Coordination of Rare Diseases at Sanford
Phase N/A · 2 location(s) · Sanford Health · NCT01793168The Efficacy and Safety of Inpegsomatropin Injection in Children With Turner Syndrome (TS) and Short Stature
Phase 3 · 51 location(s) · Xiamen Amoytop Biotech Co., Ltd. · NCT07614152Impact of Transcatheter Aortic Valve Implantation and Mitral Valve Repair on Sleep-Disordered Breathing
Phase N/A · 1 location(s) · Aristides Plaitis · NCT07520656Long-term Safety and Effectiveness of Growtropin®-II Treatment in Children With Short Stature
Phase N/A · 1 location(s) · Dong-A ST Co., Ltd. · NCT04798690Long-term Safety and Effectiveness of Growth Hormone With GHD, TS, CRF, SGA , ISS and PWS in Children
Phase N/A · 1 location(s) · LG Chem · NCT01604395Non-invasive Functional Assessment and Pathogenesis of Morquio A
Phase N/A · 1 location(s) · Nemours Children's Clinic · NCT05284006The Myelin Disorders Biorepository Project
Phase N/A · 23 location(s) · Children's Hospital of Philadelphia · NCT03047369
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.